Weekly Wellness Report Ep.1: New Tamiflu Trial Raises Serious Questions

A new clinical trial has raised serious questions about Tamiflu after researchers reported a higher mortality rate among patients who received the antiviral medication compared with those who did not.

In this week’s Weekly Wellness Report, George examines what the study found, what the results may mean, and the important limitations listeners should understand before drawing conclusions. Does the research establish that Tamiflu caused the increased deaths—or could other factors explain the difference?

We separate the alarming headline from the evidence and discuss what patients should consider when speaking with their healthcare providers about flu treatment.

Follow Wellness Talk—Where Science Meets the Soul for a new Weekly Wellness Report and our full Sunday program.

This episode is for informational purposes only and should not be considered medical advice. Never begin, discontinue, or change a medication without consulting a qualified healthcare professional.